CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $40,000 | -97.4% | 33,399 | -94.7% | 0.00% | -96.4% |
Q1 2021 | $1,512,000 | +149.9% | 630,002 | +207.0% | 0.03% | +115.4% |
Q4 2020 | $605,000 | +92.7% | 205,200 | 0.0% | 0.01% | +85.7% |
Q3 2020 | $314,000 | -38.8% | 205,200 | 0.0% | 0.01% | -30.0% |
Q2 2020 | $513,000 | +74.5% | 205,200 | +42.4% | 0.01% | +42.9% |
Q1 2020 | $294,000 | – | 144,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
RBF Capital, LLC | 159,367 | $127,000 | 0.01% |